NP / PA
Starner, Julie
Starner, Julie was paid $206K by Medicaid between Jan 2018 and Mar 2023, across 11 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoSTARNER, JULIE
ROCK HILL, NY 12775
ROCK HILL, NY 12775
33aNPI1437193521assigned 06/16/2006
33bProvider typeFamily Nurse Practitioner
28Total paid$206K
24GClaims2,243
24DCodes billed11
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Family Nurse Practitioner providers in New York
Rank by total paid#50 of 1,582
Median peer was paid$2K
This provider vs. median89×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88 | $5K | |
| 2019 | 313 | $20K | |
| 2020 | 467 | $36K | |
| 2021 | 403 | $39K | |
| 2022 | 921 | $100K | |
| 2023 | 51 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 922 | 919 | $67K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 26% | 403 | 399 | $53K |
| S9083 | Global fee urgent care centers | 19% | 284 | 282 | $38K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 401 | 399 | $31K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.4% | 118 | 117 | $11K |
| 87631 | <1% | 15 | 15 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 32 | 32 | $959.90 |
| 87634 | <1% | 12 | 12 | $842.40 | |
| 99441 | <1% | 16 | 16 | $776.64 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 28 | 28 | $677.50 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | 12 | $385.99 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.